期刊文献+

血液肿瘤CD44基因检测及4亚型克隆原核表达 被引量:2

Detection of the expression of CD44 gene in leukemia and prokaryotic expression of CD44 isoform 4 subtype in E.coli
下载PDF
导出
摘要 目的检测血液肿瘤细胞株K562、HL-60及临床急慢性粒细胞白血病患者外周血细胞CD44分子表达、分型情况,通过基因重组技术原核表达CD44分子。方法根据CD44 m RNA剪切模式设计引物,PCR扩增CD44基因,测序比对分析分子亚型,然后酶切插入原核表达载体p ET32a(+),转化大肠杆菌BL21(DE3),IPTG诱导表达后进行Western blot分析。结果9例临床标本均为CD44isoform4型,K562细胞株中未能检测到CD44,HL-60细胞株CD44为isoform4变异型;在37℃1m M的IPTG诱导2h后,CD44基因胞外区片段(h CD44om)的蛋白表达量最大,约占菌体总蛋白的48.6%,Western blot检测显示为特异性的CD44蛋白。结论 AML和CML外周血标本分子为CD44isoform4型,HL-60细胞株为CD44isoform4变异型,可能为m RNA新的剪切体及基因组不稳定突变所致;在大肠埃希菌中成功表达CD44isoform4型蛋白胞外区多肽,为后续单克隆抗体研制奠定了基础。 Objective To detect the CD44 expression and molecular classification of K562, HL-60 and samples from clinical patients with acute or chronic myeloid leukemia, and prokaryotic expression of CD44 molecule by gene recombination technology.Methods RT-PCR was applied to amplify CD44 followed by DNA sequencing and alignment with BLASTX algorithm. The fragment of h CD44 om was inserted into prokaryotic expressing vector p ET32a(+) to construct p ET32-CD44 recombinant plasmid.Then, the expression of h CD44 om in BL21(DE3) cells was induced by IPTG, and the product was identified by Western blot. Results Nine cases of clinical samples were CD44 isoform4 type, no CD44 was detected in K562 cells, and the sequence of CD44 of HL-60 was most close to CD44 isoform 4 subtype. On the other hand, we successfully cloned h CD44 om expression vector, and found that the protein h CD44 om expressed in BL21(DE3) reaching the largest amount after 2 hours cultivation with 1 m M IPTG at37℃, accounting for about 48.6% of total protein. The result of Western blot showed the CD44 has good specificity. Conclusion The CD44 of HL-60 cell line is a variant of CD44 isoform 4 which may be caused by a newly m RNA splicing, and CD44 gene of human has been successfully cloned and expressed in E. coli BL21(DE3), which laid a foundation for further developing a targeted treatment study on acute myeloid leukemia.
出处 《实验与检验医学》 CAS 2015年第1期7-10,27,共5页 Experimental and Laboratory Medicine
基金 广东省医学科研基金资助项目(编号:A2012220)
关键词 白血病干细胞 人CD44基因 原核表达 基因重组技术 Leukemic stem cells(LSCs) Human CD44 gene Prokaryotic expression Gene recombination technique
  • 相关文献

参考文献1

二级参考文献15

  • 1于晓红,李隆玉,魏宝秀,秦娜,付秋风,揭由坤,邓颖辉.CD44V6、EGFR在宫颈上皮内瘤变及宫颈鳞癌中的表达与意义[J].实用癌症杂志,2005,20(5):472-474. 被引量:8
  • 2Kay R,Rosten PM,Humphries RK.CD24,a signal transducer mod-ulating Bcell activation responses,is a very short peptide with a gly-cosyl phosphatidylinosito membrane anchor. J Immuol . 1991
  • 3Benkerrou M,Jais JP,Leblond V,et al.Anti-B-cell monoclonalantibody treatment of severe posttransplant B-lymphoproliferativedisorder:prognostic factors and long-term outcome. Blood . 1998
  • 4Kwon GY,Ha H,Ahn G,et al.Role of CD24 protein in predictingmetastatic potential of uterine cervical squamous cell carcinoma inpatients treated with radiotherapy. International Journal of Radiation Oncology Biology Physics . 2007
  • 5Sano A,Kato H,Sakurai S,et al.CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Annals of Surgical Oncology . 2009
  • 6Jothy S,Azeredo S,Moll T,et al.CD44 and its partners in metastasis. Clinical and Experimental Metastasis . 2003
  • 7Rajasagi M,Vitacolonna M,Benjak B,et al.CD44 promotes progenitor homing into the thymus and T cell maturation. Journal of Leukocyte Biology . 2009
  • 8Afify A,,Purnell P,Nguyen L.Role of CD44s and CD44v6 on humanbreast cancer cell adhesion,migration,and invasion. Experimental and Molecular Pathology . 2009
  • 9Faleiro-Rodrigues,C,Lopes.E-Cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study. Pathobiology . 2004
  • 10Sagiv E,Memeo L,Karin A,et al.CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology . 2006

共引文献1

同被引文献27

  • 1鲍立,江滨,黄晓军,王德炳,邱镜滢,卢锡京,陈欢,陆道培.Ph阳性急性淋巴细胞白血病的临床研究[J].中华血液学杂志,2005,26(1):31-34. 被引量:5
  • 2顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:476
  • 3Irving J,Jesson J,Virgo P,et al. Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytome- tryin a muhicenter setting[J].Haematologica,2009,94(6):870-874.
  • 4Campana D.Minimal residual disease monitoring in childhood acute lymphoblastie leukemia [J].Curr Opin Hematol,2012,19 (4):313- 318.
  • 5Coustan-Smith E,Campana D.Immunologic minimal residual dis- ease detection in acute lymphoblastic leukemia: a comparative ap- proach to molecular testing [J].Best Pract Res Clin Haematol, 2010,23(3):347-358.
  • 6Pui CH, Campena D, Pei D, et al. Treating childhood acute lym- phoblastic leukemia without cranial irradiation [J].N Engl J Med, 2009,360(26):2730-2741.
  • 7Hong D,Gupta R,Ancliff P,et al.Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia [J].Science, 2008,319(5861):336-339.
  • 8Teachey DT,Hunger SP.Predicting relapse risk in childhood acute lymphoblastic leukemia~JJ.Br J Haematol,2013,162(5):606-620.
  • 9Gao C,Zhao XX,Li WJ,et al.Clinical features,early treatment re- sponses,and out-comes of pediatric acute lymphoblastic leukemia in china with or without specific fusion transcripts:A single institu-tional study of 1,004 patients[J].Am J Hemato12012,87(11):1022- 1027.
  • 10Thomas D.Childhood Philadelphia chromosome-positive B lym- phoblastic leukaemia [J].Lancet Oncol,2012,13(9):860-863.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部